An intervention to decrease catheter-related bloodstream infections in the ICU
Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel, Peter Pronovost, Dale Needham, Sean Berenholtz, David Sinopoli, Haitao Chu, Sara Cosgrove, Bryan Sexton, Robert Hyzy, Robert Welsh, Gary Roth, Joseph Bander, John Kepros, Christine Goeschel
Abstract
Background: Catheter-related bloodstream infections occurring in the intensive care unit (ICU) are common, costly, and potentially lethal.
Methods: We conducted a collaborative cohort study predominantly in ICUs in Michigan. An evidence-based intervention was used to reduce the incidence of catheter-related bloodstream infections. Multilevel Poisson regression modeling was used to compare infection rates before, during, and up to 18 months after implementation of the study intervention. Rates of infection per 1000 catheter-days were measured at 3-month intervals, according to the guidelines of the National Nosocomial Infections Surveillance System.
Results: A total of 108 ICUs agreed to participate in the study, and 103 reported data. The analysis included 1981 ICU-months of data and 375,757 catheter-days. The median rate of catheter-related bloodstream infection per 1000 catheter-days decreased from 2.7 infections at baseline to 0 at 3 months after implementation of the study intervention (P< or =0.002), and the mean rate per 1000 catheter-days decreased from 7.7 at baseline to 1.4 at 16 to 18 months of follow-up (P<0.002). The regression model showed a significant decrease in infection rates from baseline, with incidence-rate ratios continuously decreasing from 0.62 (95% confidence interval [CI], 0.47 to 0.81) at 0 to 3 months after implementation of the intervention to 0.34 (95% CI, 0.23 to 0.50) at 16 to 18 months.
Conclusions: An evidence-based intervention resulted in a large and sustained reduction (up to 66%) in rates of catheter-related bloodstream infection that was maintained throughout the 18-month study period.
Copyright 2006 Massachusetts Medical Society.
Source: PubMed
Próximos ensaios clínicos
-
Kanglin Biotechnology (Hangzhou) Co., Ltd.Ainda não está recrutandoDoença de Parkinson (DP) | Advanced Primary PDChina
-
Carilion ClinicRecrutamentoHematoma Subdural Crônico | RecorrenteEstados Unidos
-
Mahidol UniversityAinda não está recrutandoCâncer de mama | Carcinoma Ductal In Situ
-
Biosensors Europe SAAinda não está recrutandoNSTEMI | Angina Instável (AI) | Angina (estável)Reino Unido
-
CooperVision International Limited (CVIL)Ainda não está recrutando
-
Shanghai Yueyang Integrated Medicine HospitalRecrutamentoSarcopenia em IdososChina
-
University of Management and Technology LahoreAinda não está recrutandoFarward Head PosturePaquistão
-
China National Center for Cardiovascular DiseasesAinda não está recrutandoBalão revestido de drogas | Ultrassom Intravascular | De Novo Large Coronary VesselChina
-
Korea University Anam HospitalAinda não está recrutandoFA - Fibrilação AtrialCoréia do Sul
-
Jijun WangRecrutamento
-
DiproBio (Shanghai) Co., Ltd.Ainda não está recrutandoSaúde mental | Estresse psicológicoChina
-
Emory UniversityAinda não está recrutandoGravidez relacionada | Hypertensive Disorder of Pregnancy (HDP)Estados Unidos